Dókus Levente E, Menyhárd Dóra K, Tantos Ágnes, Hudecz Ferenc, Bánóczi Zoltán
MTA-ELTE Research Group of Peptide Chemistry, Hungarian Academy of Sciences (HAS), Eötvös Loránd University (ELTE), Budapest, Hungary.
Laboratory of Structural Chemistry and Biology and MTA-ELTE Protein Modeling Group, Eötvös Loránd University, Budapest, Hungary.
Eur J Med Chem. 2014 Jul 23;82:274-80. doi: 10.1016/j.ejmech.2014.05.058. Epub 2014 May 24.
Calpains are intracellular cysteine proteases with important physiological functions. Up- or downregulation of their expression can be responsible for several diseases, therefore specific calpain inhibitors may be considered as promising candidates for drug discovery. In this paper we describe the synthesis and characterization of a new class of inhibitors derived from the analysis of amino acid preferences in primed and unprimed sites of calpains by incorporation of l- or d-epoxysuccinyl group (Eps). Amino acids for replacement were chosen by considering the substrate preference of calpain 1 and 2 enzymes. The compounds were characterized by RP-HPLC, amino acid analysis and ESI-MS. Selectivity of the compounds was studied by using calpain 1 and 2; and cathepsin B. We have identified five calpain specific inhibitors with different extent of selectivity. Two of these also exhibited isoform selectivity. Compound NH2-Thr-Pro-Leu-(d-Eps)-Thr-Pro-Pro-Pro-Ser-NH2 proved to be a calpain 2 enzyme inhibitor with at least 11.8-fold selectivity, while compound NH2-Thr-Pro-Leu-(l-Eps)-Ser-Pro-Pro-Pro-Ser-NH2 possesses calpain 1 enzyme inhibition with at least 4-fold selectivity. The results of molecular modeling calculations suggest that the orientation of the bound inhibitor in the substrate binding cleft is markedly dependent on the stereochemistry of the epoxysuccinyl group.
钙蛋白酶是具有重要生理功能的细胞内半胱氨酸蛋白酶。其表达的上调或下调可能引发多种疾病,因此特定的钙蛋白酶抑制剂有望成为药物研发的候选对象。在本文中,我们描述了一类新型抑制剂的合成与表征,这类抑制剂是通过对钙蛋白酶引发位点和未引发位点的氨基酸偏好进行分析,引入L-或D-环氧琥珀酰基团(Eps)而得到的。通过考虑钙蛋白酶1和2的底物偏好来选择用于替换的氨基酸。这些化合物通过反相高效液相色谱(RP-HPLC)、氨基酸分析和电喷雾质谱(ESI-MS)进行表征。利用钙蛋白酶1和2以及组织蛋白酶B研究了这些化合物的选择性。我们鉴定出了五种具有不同选择性程度的钙蛋白酶特异性抑制剂。其中两种还表现出同工型选择性。化合物NH2-Thr-Pro-Leu-(d-Eps)-Thr-Pro-Pro-Pro-Ser-NH2被证明是一种对钙蛋白酶2具有至少11.8倍选择性的抑制剂,而化合物NH2-Thr-Pro-Leu-(l-Eps)-Ser-Pro-Pro-Pro-Ser-NH2对钙蛋白酶1具有至少4倍选择性的抑制作用。分子模拟计算结果表明,结合的抑制剂在底物结合裂隙中的取向明显取决于环氧琥珀酰基团的立体化学。